Sherbrooke Park Advisers’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,401
Closed -$187K 584
2025
Q1
$187K Buy
+14,401
New +$191K 0.09% 434

Other funds holding DVAX

Sherbrooke Park Advisers's DVAX Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 14,401 shares — an estimated $187K sold.

Sherbrooke Park Advisers first reported a position in DVAX in Q1 2025 and held it in 1 quarter. The position peaked at $187K in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 14,401 Dynavax Technologies shares in Q2 2025, an estimated $187K.
  • Sherbrooke Park Advisers first reported a position in Dynavax Technologies in Q1 2025 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Dynavax Technologies position peaked at $187K in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.